Lung nodules
Does your patient wish to be referred?
Minimum referral criteria
Does your patient meet the minimum referral criteria?
Category 1
Appointment within 30 days is desirable
Lung nodules are traditionally defined as ≤30 mm in diameter. This section is relevant to both screening detected and incidental (scan performed for a different reason) lung nodules.
Any one of the following:
Solid | Part Solid | Non-solid (Ground glass) | |
National Lung Cancer Screening Program |
|
||
Nodule Size[1] | >8 mm | Solid component >8 mm | |
Nodule volume[2] | ≥268 mm3 | Solid component ≥268 mm3 | |
Change from previous scans (within 24 months) |
|
|
|
Other features |
|
[1]Dimensions are average of long and short axes, rounded to the nearest millimetre. Where only the largest diameter is provided in the imaging Report, this measurement can be considered
[2]Volume calculated from radiology volumetric software.
Category 2
Appointment within 90 days is desirable
Any one of the following:
Solid | Part Solid | Non-solid (Ground glass) | |
National Lung Cancer Screening Program |
|
||
Nodule Size[1] | 6–8 mm | Solid component 6–8 mm | ≥30 mm |
Nodule volume[2] | ≥113 to <268 mm3 | Solid component 113 to <268 mm3 | |
Change from previous scans (within 24 months) | Nodule 4 to <8 mm (113 to <268 mm3) which is new or growing | Solid component of nodule <4 mm (<34 mm3) which is new or growing |
|
Other features |
|
[1]Dimensions are average of long and short axes, rounded to the nearest millimetre. Where only the largest diameter is provided in the imaging Report, this measurement can be considered as a surrogate for the average.
[2]Volume calculated from radiology volumetric software.
Category 3
Appointment within 365 days is desirable
- There are no Category 3 criteria. Support for managing nodules <6 mm (that do not meet criteria for change from previous scans above) can be obtained by Request for Advice, if required.
If your patient does not meet the minimum referral criteria
Consider other treatment pathways or an alternative diagnosis.
If you still need to refer your patient:
- Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
- Please note that your referral may not be accepted or may be redirected to another service
Other important information for referring practitioners
Not an exhaustive list
- Refer to HealthPathways or local guidelines
- National Lung Cancer Screening Program:
- Fleischer Society Guidelines 2017 | Timing for Follow-Up CT scans for incidental Lung Nodules[1]
Type | Risk[2] | <6 mm | 6-8 mm (≥6 for subsolid) | |
Solid | Single | Low | None | 6-12 months then consider at 18-24 months |
High | 12 months(optional) | 6-12 months then at 18-24 months | ||
Multiple | Low | None | 3-6 months then consider at 18-24 months | |
High | 12 months (optional) | 3-6 months then at 18-24 months | ||
Non-solid | No routine follow-up | 6-12 months then 2-yearly for 5 yrs | ||
Part-solid | No routine follow-up | 3-6 months then yearly for 5 yrs | ||
Multiple | 3-6 months then annual for 5 years | 6-12 months then based on most suspicious |
[1]Not intended for patients <35 years, lung cancer screening, history of cancer or immunocompromised
[2]High-risk factors include older age, heavy smoking, irregular or spiculated margins, and upper lobe location.
- Nodules that do not require referral include:
- Nodules with diffuse, central, laminated or popcorn patterns of calcification or macroscopic fat
- Juxtapleural (perifissural) nodules with characteristic triangular morphology < 10 mm diameter
- Solid nodules stable for at least 2 years
- Non-solid, part solid and atypical pulmonary cysts stable for at least 5 years
- Review of previous imaging is very important to determine if nodules are new, enlarging, stable or decreased.
- Follow up imaging of nodules should be performed at the same radiology service and on the same equipment, if possible.
Referral requirements
A referral may be rejected without the following information.
- Chest imaging and details of radiology provider
- Details and pathology results (if available) of previous malignancies
- NLCSP screening report, if applicable
- Patient characteristics which influence risk of malignancy:
- Personal history of cancers
- Patient history, symptoms, and indication for CT (if CT performed for respiratory (infective) symptoms, consider short interval repeat CT depending on radiological likelihood of malignancy (e.g., 8–12 weeks)
- Detailed smoking history including tobacco, marijuana, electronic cigarettes, and illicit drugs
- Family history of lung cancer
- Ethnicity
- Occupational exposures
- Known underlying lung disease, for example, COPD, Interstitial lung disease
- Medications, for example, anticoagulation, immunosuppressive drugs
Additional Referral Information (Useful for processing the referral)
- Historical imaging (if available)
- FBC, ELFT and any other relevant pathology results
Out of catchment
Metro North Health is responsible for providing public health services to the people who reside within its boundaries. Special consideration is made for patients requiring tertiary care or services that are not provided by their local Hospital and Health Service. If your patient lives outside the Metro North Health area and you wish to refer them to one of our services, inclusion of information regarding their particular medical and social factors will assist with the triaging of your referral.
- Impact on employment
- Impact on education
- Impact on home
- Impact on activities of daily living
- Impact on ability to care for others
- Impact on personal frailty or safety
- Identifies as Aboriginal and/or Torres Strait Islander
- To establish a diagnosis
- For treatment or intervention
- For advice and management
- For specialist to take over management
- Reassurance for GP/second opinion
- For a specified test/investigation the GP can’t order, or the patient can’t afford or access
- Reassurance for the patient/family
- For other reason (e.g. rapidly accelerating disease progression)
- Clinical judgement indicates a referral for specialist review is necessary
- Presenting symptoms (evolution and duration)
- Physical findings
- Details of previous treatment (including systemic and topical medications prescribed) including the course and outcome of the treatment
- Body mass index (BMI)
- Details of any associated medical conditions which may affect the condition or its treatment (e.g. diabetes), noting these must be stable and controlled prior to referral
- Current medications and dosages
- Drug allergies
- Alcohol, tobacco and other drugs use
- Full name (including aliases)
- Date of birth
- Residential and postal address
- Telephone contact number/s – home, mobile and alternative
- Medicare number (where eligible)
- Name of the parent or caregiver (if appropriate)
- Preferred language and interpreter requirements
- Identifies as Aboriginal and/or Torres Strait Islander
- Full name
- Full address
- Contact details – telephone, fax, email
- Provider number
- Date of referral
- Signature
- Willingness to have surgery (where surgery is a likely intervention)
- Choice to be treated as a public or private patient
- Compensable status (e.g. DVA, Work Cover, Motor Vehicle Insurance, etc.)
Send referral
Hotline: 1300 364 938
Medical Objects ID: MQ40290004P
HealthLink EDI: qldmnhhs
Mail:
Metro North Central Patient Intake
Aspley Community Centre
776 Zillmere Road
ASPLEY QLD 4034
Health pathways
Access to Health Pathways is free for clinicians in Metro North Brisbane.
For login details email:
healthpathways@brisbanenorthphn.org.au
Login to Brisbane North Health Pathways:
brisbanenorth.healthpathwayscommunity.org